1st Quarter - Amendment

AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC. for AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC

Firm
Client
Income
—
Expenses
$610,000
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
1st Quarter - Report Apr 21, 2014 $760,000 Replaced
1st Quarter - Amendment (this page) Jul 21, 2014 $610,000 Yes

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Issues relating to the tax treatment of nonprofits, deductability of charitable donations, including governance of nonprofit organizations. Includes taxpayer deductibility and tobacco tax provisions in the President's FY15 Budget.

LobbyistCovered position, as disclosed
GREGG HAIFLEY —
VICTORIA SENG —
RICHARD WOODRUFF —

Contacted: U.S. Trade Representative (USTR); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE; Food & Drug Administration (FDA); Natl Institutes of Health (NIH); White House Office; U.S. Agency for International Development (USAID); Centers For Disease Control & Prevention (CDC); Labor, Dept of (DOL); State, Dept of (DOS); Environmental Protection Agency (EPA)

Health Issues HCR

Issues relating to health disparities, health care reform, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including the following legislation to be reintroduced from the 112th Congress: H.R.1851 and S.881, the Family Act; the as-yet not introduced Health Equity and Accountability Act; H.R.1666, the Patient Centered Quality Care For Life Act, and, H.R.1339 & S.641, the Palliative Care andHospice Education and Training Act; S.621 and H.R.2607 and S.1251, the Caroline Pryce Walker Conquer Childhood Cancer Act; H.R.2058 & S.1247 the Childhood Cancer Survivors Quality of Life Act; H.R.2019, the Kids First Research Act; and H.R.460, the Patients' Access to Treatments Act; H.R.3404, the Breast Density & Mammography Reporting Act, H.R.4250 and S.2141, legislation to create a new FDA approval pathway for O.T.C. sunscreen products.

Contacted: Food & Drug Administration (FDA); Environmental Protection Agency (EPA); HOUSE OF REPRESENTATIVES; U.S. Agency for International Development (USAID); Health & Human Services, Dept of (HHS); Labor, Dept of (DOL); State, Dept of (DOS); White House Office; U.S. Trade Representative (USTR); Centers For Disease Control & Prevention (CDC); Natl Institutes of Health (NIH); SENATE; Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 2019 (113th), S. 1247 (113th), S. 2141 (113th), H.R. 2058 (113th), S. 1251 (113th), S. 881 (113th), H.R. 2607 (113th), H.R. 460 (113th), S. 641 (113th), H.R. 1851 (113th), H.R. 1666 (113th), H.R. 3404 (113th), H.R. 4250 (113th), S. 621 (113th), H.R. 1339 (113th)

Medicare/Medicaid MMM

Issues relating to implementation of changes to Medicare and Medicaid, pursuant to P.L. 111-148, the Patient Protection and Affordable Care Act of 2010, and tobacco cessation programs within Medicaid. Issues relating to inclusion of palliative care as a bundled service within CMS "value-based purchasing", general deficit reduction issues impacting Medicare & Medicaid, and H.R.1070, Removing Barriers to Colorectal Cancer Screening Act of 2013; H.R.2810, Medicare Patient Access & QualityImprovement Act, S.1871, the SGR Repeal & Medicare Beneficiary Access Act, and S. 2157, the Commonsense Medicare SGR Repeal and Beneficiary Access Improvement Act of 2014.

LobbyistCovered position, as disclosed
SARAH BOGDAN —
OKEYSHA BROOKS-COLEY —
GREGG HAIFLEY —
KATRINA KAMM New —
PATRICIA MALLIOS —
MATTHEW PHELAN —
VICTORIA SENG —
MONA SHAH —
RICHARD WOODRUFF —

Contacted: U.S. Agency for International Development (USAID); SENATE; White House Office; Environmental Protection Agency (EPA); Natl Institutes of Health (NIH); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); U.S. Trade Representative (USTR); Centers For Disease Control & Prevention (CDC); Centers For Medicare and Medicaid Services (CMS); State, Dept of (DOS); Food & Drug Administration (FDA); Labor, Dept of (DOL)

Bills named: H.R. 1070 (113th), H.R. 2810 (113th), S. 2157 (113th), S. 1871 (113th)

Budget/Appropriations BUD

Federal budget and appropriations for cancer research and programs, including federal appropriations for NIH, NCI, CDC, FDA; the Prevention & Public Health Fund; the Affordable Care Act provisions; programs for breast and cervical cancer, colorectal cancer, tobacco regulation and cessation, patient navigators, patient quality of life, and international health. President Obama's FY15 budget, S.1284, the FY14 Labor, Health & Human Resources Appropriations Act; H.J.Res.59, Continuing Resolution; H.R.2775,Continuing Appropriations; and H.R.3547, Omnibus Appropriations for FY14, and matters relating to the impact of the government-wide sequester as it affects CDC, NIH, NCI, Prevention & Public Health Fund, and other appropriated accounts relating to cancer.

Contacted: HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); State, Dept of (DOS); Health & Human Services, Dept of (HHS); White House Office; Environmental Protection Agency (EPA); Food & Drug Administration (FDA); SENATE; U.S. Agency for International Development (USAID); Centers For Medicare and Medicaid Services (CMS); Natl Institutes of Health (NIH); Centers For Disease Control & Prevention (CDC); Labor, Dept of (DOL)

Bills named: H.J.Res. 59 (113th), H.R. 2775 (113th), H.R. 3547 (113th), S. 1284 (113th)

Tobacco TOB

Issues relating to smoking cessation, tobacco sales to minors, tobacco taxes, product regulation, and smokefree environments, including: (1) implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31): (2) cessation and prevention programs authorized as part of P.L. 111-148, the Patient Protection & Affordable Care Act of 2010; (3) Framework Convention on Tobacco Control (FCTC). S.39, Healthy Lifestyles and Prevention America Act, H.R.792 & S.772, cigar exemptionfrom FDA regulations; S.194, Tobacco Tax Equity Act and tobacco tax proposals contained in the President's FY15 Budget. Issues relating to tobacco and trade, including the Trans-Pacific Partnership and Transatlantic Trade and Investment Partnership, and legislation relating to trade promotion authority.

LobbyistCovered position, as disclosed
OKEYSHA BROOKS-COLEY —
GREGG HAIFLEY —
GRETA JOHNSON —
KATRINA KAMM New —
PATRICIA MALLIOS —
MATTHEW PHELAN —
DAVID PUGACH —
SARA SAHLI —
VICTORIA SENG —
MONA SHAH —
RICHARD WOODRUFF —

Contacted: SENATE; White House Office; State, Dept of (DOS); Centers For Medicare and Medicaid Services (CMS); Centers For Disease Control & Prevention (CDC); HOUSE OF REPRESENTATIVES; U.S. Agency for International Development (USAID); Natl Institutes of Health (NIH); Environmental Protection Agency (EPA); Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); U.S. Trade Representative (USTR); Labor, Dept of (DOL)

Bills named: S. 39 (113th), H.R. 792 (113th), S. 194 (113th), S. 772 (113th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.